title: Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir.
abstract: The fixed-dose combination of Efavirenz/Emtricitabine/Tenofovir is a first-line agent for the treatment of HIV; however few cases have reported hepatotoxicity associated with the drug. We report a case of Efavirenz/Emtricitabine/Tenofovir-associated hepatotoxicity presenting mainly with hepatocellular injury characterized by extremely elevated aminotransferase levels, which resolved without acute liver failure or need for liver transplant referral.
authors.affiliation: Department of Internal Medicine, NYU Lutheran Medical Center, Brooklyn, NY 11220, USA.
authors.forename: Rashmee
authors.initials: R
authors.lastname: Patil
authors.affiliation: Department of Gastroenterology & Hepatology, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
authors.forename: Mel A
authors.initials: MA
authors.lastname: Ona
authors.affiliation: Department of Gastroenterology & Hepatology, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
authors.forename: Haris
authors.initials: H
authors.lastname: Papafragkakis
authors.affiliation: Department of Infectious Diseases, NYU Lutheran Medical Center, Brooklyn, NY 11220, USA.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Carey
authors.affiliation: Department of Gastroenterology & Hepatology, NYU Lutheran Medical Center, Brooklyn, NY 11220, USA.
authors.forename: Yitzchak
authors.initials: Y
authors.lastname: Moshenyat
authors.affiliation: Department of Internal Medicine, NYU Lutheran Medical Center, Brooklyn, NY 11220, USA.
authors.forename: Adib
authors.initials: A
authors.lastname: Alhaddad
authors.affiliation: Department of Gastroenterology & Hepatology, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
authors.forename: Sury
authors.initials: S
authors.lastname: Anand